Navigation Links
Classical monographs re-published in advanced open access
Date:6/11/2014

Easy access to legacy data collected over hundreds-of-years of exploration of nature from the convenience of people's own computers for anyone all over the world? It may sound futuristic but a brand new pilot showcases how this is possible here and now.

The new workflow demonstrates a re-publication of a volume of Flora Malesiana in a semantically enriched HTML edition available on the newly launched, Advanced Books publishing platform. The platform was demonstrated today at the EU funded pro-iBiosphere project which supported, in part, the re-publication of Flora Malesiana.

When Linnaeus was laying the foundations of taxonomy as a science in his Species Plantarum and Systema Naturae books he probably did not imagine that his methods of publication of natural history data would remain almost unchanged for more than 270 years! The bulk of the information on the living World is still closed in paper-based legacy literature, especially in fundamental regional treatises such as Flora, Fauna and Mycota series, hardly accessible for readers, despite the dramatic changes in the publishing technologies that have taken place over the last decade.

The new pilot, developed by Pensoft Publishers in a cooperation with the Naturalis Biodiversity Center, Plazi, and Botanischer Garten und Botanisches Museum Berlin-Dahlem (BGBM), demonstrates how a fundamental book in natural history can start a new life with Advanced Books. Re-publication of the Flora of Northumberland & Durham, published in 1838, will be the next to appear as a result of a collaboration between the Botanical Garden Mei
'/>"/>

Contact: Lyubomir Penev
penev@pensoft.net
Pensoft Publishers
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Geniposide protects hippocampal neurons via the non-classical estrogen signaling pathway
2. Weeding out invasive species with classical biological control
3. UK invests in worlds most advanced crystallography facility
4. Phase I data suggest PLX3397 is a potential therapy for patients with advanced PVNS
5. Molecular tumor board helps in advanced cancer cases
6. Research center to develop next generation of advanced chemical products
7. Umeå University becomes national resource for advanced electron microscopy
8. Scientists invent advanced approach to identify new drug candidates from genome sequence
9. BBSRC announces £10M of funding for advanced scientific equipment
10. MU researchers develop advanced 3-dimensional force microscope
11. KaloBios Announces Preliminary Phase 1 Results in Advanced Hematologic Malignancies with KB004, an Anti-EphA3 Monoclonal Antibody
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Classical monographs re-published in advanced open access
(Date:2/12/2015)... 12, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... 62/113114 for DISTRIBUTED METHOD AND SYSTEM TO ... patent further establishes NXT-ID,s position in the emerging "Internet ... the ability for multiple devices to collaborate with one ...
(Date:2/5/2015)... RESEARCH TRIANGLE PARK, N.C. , Feb. 5, 2015 ... as a specialist logistics company and has launched a ... industry,s only Clinical Logistics Organization (CLO).  The new campaign ... with emphasis on patient, protocol and shipments. ... Patient First , aligns Marken,s priorities with its ...
(Date:2/5/2015)... Jan. 28, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... RedChip Global Online CEO Conference on January 29 th ... Gino Pereira , CEO of NXT-ID will present and ... the Wocket smart wallet and its full suite of ...
Breaking Biology News(10 mins):NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Marken Launches New Patient-Centric Campaign 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3
... Iowa State University researchers have developed a technology that ... cervical cancer in women. Thats a significant improvement ... Edward Yeung, an Iowa State Distinguished Professor and the ... research team that developed the new test. The current ...
... percent increase in lifespan, raising the tantalizing question of ... taking an anti-aging medication. Results of the Buck Institute ... are currently published online in the Journal of Biological ... mood affective disorders, including bipolar disease for decades. While ...
... Monmouth University,s Urban Coast Institute will host its ... 2007, from 10 a.m. to 12 p.m., in the ... an Ocean Literate Society: Building Communities for Action," will ... of communication will be used to increase the general ...
Cached Biology News:Iowa State researchers develop technology for early detection of viruses 2Drug commonly used to treat bipolar disorder dramatically increases lifespan in worms 2Abel to receive posthumous Ocean and Coastal Leadership award 2
(Date:3/3/2015)...  Rosa & Co. LLC, a drug development advisory ... today announced it has two posters scheduled to be ... and Therapeutics meeting in New Orleans, LA ... - http://photos.prnewswire.com/prnh/20150302/179058LOGO   Bristol- Myers ... a quantitative systems pharmacology approach for immuno-oncology drug development ...
(Date:3/3/2015)... 03, 2015 Cambridge Semantics, the leading ... technology, today announced that it has been named to ... in Knowledge Management.’ , To create the list ... analysts and system integrators who identify organizations dedicated to ... right information to the right people at the right ...
(Date:3/3/2015)... , March 3, 2015 ... tools for implementing competency-based training to comply with new ... is offering a new crosswalk tool ... implement competency-based training for direct service workers as a ... Medicaid Services (CMS) regulations. CMS amended the ...
(Date:3/3/2015)... GlobalStemCellsGroup.com has recruited Mario ... a biomedical researcher and founding partner of Criogenix SA ... of biomedical professors who will teach the “Diplomat in ... de CV is a private company registered in the ... in Mexico (RENIECYT). , Camacho Alcocer will teach two-day, ...
Breaking Biology Technology:Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 2Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 3Cambridge Semantics Named to KMWorld’s 2015 ‘100 Companies That Matter in Knowledge Management’ 2Elsevier's DirectCourse Can Help States Meet and Exceed New CMS Requirements for Home and Community-Based Services 2Elsevier's DirectCourse Can Help States Meet and Exceed New CMS Requirements for Home and Community-Based Services 3Mario Camacho Alcocer Joins Global Stem Cells Group Faculty 2Mario Camacho Alcocer Joins Global Stem Cells Group Faculty 3
... 2012  Agendia, an innovative molecular cancer diagnostics company, ... contract with Blue Shield of California, making Agendia ... for future in-network coverage for MammaPrint® and other ... United States. Developed and commercialized by Agendia, MammaPrint ...
... Jan. 5, 2012 CMC Biologics, a leading ... European Patent No. US 2,171,034 B1 covering a ... mammalian cell culture bioreactors. The invention is designed ... continuous perfusion fermentation process, wherein the bioreactor (fermenter) ...
... (Nasdaq: NKTR ) President and Chief Executive Officer, ... 30th Annual J.P. Morgan Healthcare Conference in San Francisco at ... at 8:30 a.m. Pacific time. The presentation will ... the Investor Relations, Events Calendar section of the Nektar website: ...
Cached Biology Technology:Agendia Signs Contract with Blue Shield of California 2CMC Biologics Strengthens its Innovative Biomanufacturing Technology Portfolio in Continuous Perfusion Systems 2Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the 30th Annual J.P. Morgan Healthcare Conference in San Francisco, CA 2
IMAGEQUANT 400 WKSTN, 1 EA. Category: ImageQuant CCD Imagers....
PAb to Hu-IFN-Alpha/Beta R2 [(IFNAR2) CD118], Rabbit Serum, neutralizing Binds to but does not neutralize human interferon alpha/beta receptor...
ANTI MYCOBACTERIUM TUBERCULOSIS...
ImageQuant 400, 1 EA. Category: ImageQuant CCD Imagers....
Biology Products: